clinical trial · NCT01764178
To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet
JW Pharmaceutical·phase1·completed·n = 52
HyperlipidemiaHypertensionLivalo fixed combination drugPitavastatin, Valsartan
brief summary
The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.
started
Jan 22, 2013
primary completion
Mar 15, 2013
completion
Dec 27, 2013
last updated
Sep 9, 2025
official title
A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatn and Valsartan Co-administration and Livalo Complex Product in Healthy Male Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol